- Event-free survival in patients with polycythemia vera treated with ropeginterferon alfa-2b versus best available treatment2023 | Publication without faculty affiliation
- Novel tumor antigens elicit anti-tumor humoral immune reactions in a subset of patients with polycythemia vera2007 | First Faculty of Medicine
- Novel tumor antigens elicit anti-tumor humoral immune reactions in a subset of patients with polycythemia vera2007 | Faculty of Physical Education and Sport
- A novel uncoventional antigen MPD5 elicits anti-tumor humoral immune responses in a subset of patients with polycythemia vera2007 | First Faculty of Medicine
- A novel uncoventional antigen MPD5 elicits anti-tumor humoral immune responses in a subset of patients with polycythemia vera2007 | Faculty of Physical Education and Sport
- Life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemia2005 | First Faculty of Medicine
- Final report of University Hospital Hradec Kralove to the clinical trial protocol no. PROUD-PVPublication without faculty affiliation
- Report of University Hospital Hradec Králové to the clinical trial protocol No: PROUD-PVPublication without faculty affiliation
- Clinical and molecular characterisation of a prospectively collected cohort of children and adolescents with polycythemia vera2008 | Second Faculty of Medicine